CISPLATIN, METHOTREXATE, AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER

被引:30
作者
CONTE, PF
SERTOLI, MR
BRUZZONE, M
RUBAGOTTI, A
ROSSO, R
BENTIVOGLIO, G
CONIO, A
PESCETTO, G
机构
[1] UNIV GENOA,IST NAZL RIC CANC,DIV ONCOL MED 1,I-16126 GENOA,ITALY
[2] UNIV GENOA,OSTET & GINECOL CLIN,I-16126 GENOA,ITALY
关键词
D O I
10.1016/0090-8258(85)90210-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:290 / 297
页数:8
相关论文
共 15 条
  • [1] AURE JC, 1977, OBSTET GYNECOL, V37, P1
  • [2] BARKER GH, 1981, LANCET, V1, P747
  • [3] IMPROVED THERAPY WITH CISPLATIN REGIMENS FOR PATIENTS WITH OVARIAN-CARCINOMA (FIGO STAGE-III AND STAGE-IV) AS MEASURED BY SURGICAL END-STAGING (2ND-LOOK OPERATION)
    COHEN, CJ
    GOLDBERG, JD
    HOLLAND, JF
    BRUCKNER, HW
    DEPPE, G
    GUSBERG, SB
    WALLACH, RC
    KABAKOW, B
    RODIN, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (08) : 955 - 967
  • [4] A PROSPECTIVE RANDOMIZED CLINICAL-TRIAL OF MELPHALAN AND CIS-PLATINUM VERSUS HEXAMETHYLMELAMINE, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CANCER
    EDWARDS, CL
    HERSON, J
    GERSHENSON, DM
    COPELAND, LJ
    WHARTON, JT
    [J]. GYNECOLOGIC ONCOLOGY, 1983, 15 (02) : 261 - 277
  • [5] EHRLICH CE, 1979, CANCER TREAT REP, V63, P281
  • [6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [7] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
    OKEN, MM
    CREECH, RH
    TORMEY, DC
    HORTON, J
    DAVIS, TE
    MCFADDEN, ET
    CARBONE, PP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06): : 649 - 655
  • [8] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES
    PETO, R
    PIKE, MC
    ARMITAGE, P
    BRESLOW, NE
    COX, DR
    HOWARD, SV
    MANTEL, N
    MCPHERSON, K
    PETO, J
    SMITH, PG
    [J]. BRITISH JOURNAL OF CANCER, 1977, 35 (01) : 1 - 39
  • [9] PETO R, 1976, BRIT J CANCER, V34, P385
  • [10] SILVERBERG E, 1981, CA-CANCER J CLIN, V31, P13